|
|
||||||||
Ann Thorac Surg 1997;64:1204-1211
© 1997 The Society of Thoracic Surgeons
Department of Vascular Surgery and Molecular Genetics Unit, Kolling Institute for Medical Research, Royal North Shore Hospital, Sydney, Australia
Cardiovascular disease and cancer account for the majority of adult disease in the developed world. This review focuses on current concepts in the study of angiogenesis (new vessel formation) as related to these conditions and highlights the role of vascular endothelial growth factor. Developments in therapeutic angiogenesis have raised the possibility that pharmacologic or gene-directed interventions, based on the ability of vascular endothelial growth factor to promote new vessel formation, may soon gain clinical application for the treatment of occlusive vascular disease. Similarly, the future treatment of malignant disease is likely to involve antiangiogenic agents that, in preliminary animal work, have demonstrated an efficacy that is not limited by adverse affects. Aside from these potential applications, current investigations have enhanced our understanding of mechanisms involved in the development of atherosclerotic and malignant disease.
This article has been cited by other articles:
![]() |
A. Jackson, A. Kassner, D. Annesley-Williams, H. Reid, X.-P. Zhu, and K.-L. Li Abnormalities in the Recirculation Phase of Contrast Agent Bolus Passage in Cerebral Gliomas: Comparison with Relative Blood Volume and Tumor Grade AJNR Am. J. Neuroradiol., January 1, 2002; 23(1): 7 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Favaloro Landmarks in the Development of Coronary Artery Bypass Surgery Circulation, August 4, 1998; 98(5): 466 - 478. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |